CLPS Incorporation has extended its existing share repurchase program, originally set to expire in November 2026, by an additional eight months until July 3, 2027. The program allows the company to buy back up to 1,000,000 common shares, with 240,841 shares already repurchased and 759,159 shares remaining available. This extension enables CLPS to continue repurchasing shares through various market transactions, supporting shareholder value. The Board will periodically review the program and may adjust or suspend it as needed.
CLPS Incorporation's share repurchase program extension is the subject, with Pluang market data providing context as of Oct 29, 2026 19:13 WIB. For readers following Technology-sector US stocks, here is Pluang's market snapshot: out of 150 stocks, 21 rose and 127 fell. Notable movers include OKTA at USD 206.95 with a -7.06% change and 100% buy order activity, CRWD at USD 247.95 with a -7.02% change and 74% sell order activity, and PANW at USD 367.02 with a -6.96% change and 91% buy order activity.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
